53rd Annual Meeting of the European Society of Blood and Marrow Transplantation (EBMT 2027)

The 53rd Annual Meeting of the European Society of Blood and Marrow Transplantation (EBMT 2027) focuses on advancements in hematopoietic stem cell transplantation, cell therapy, and gene therapy, with a strong emphasis on disease-specific treatments, quality management, and data management.

Key Topics

• Disease-specific topics
  • Aplastic anaemia
  • Acute leukaemia
  • Chronic leukaemia
  • Autoimmune diseases
  • Lymphoma
  • Haemoglobinopathy and Inborn errors of metabolism
  • Myelodysplasia
  • Multiple myeloma
  • Solid tumours
• General Topics
  • Hematopoietic stem cells
  • Cell therapy
  • Gene Therapy
  • Regenerative medicine
  • Stem cell mobilisation and Graft engineering
  • Non-hematopoietic stem cells
• QUALITY MANAGEMENT GROUP
  • Quality management
  • Accreditation
  • Sharing best practice
  • Regulatory issues
• Transplant-specific topics
  • Stem cell donor
  • Stem cell source
  • Graft-versus-host disease – clinical
  • Graft-versus-host disease – preclinical and animal models
  • Early complications / Late effects & quality of life
  • Infectious complications
  • Minimal residual disease, Tolerance, Chimerism and Immune reconstitution
  • Reduced-intensity conditioning
  • Experimental stem cell transplantation and Tumour stem cells
  • Paediatric issues
• DATA MANAGEMENT GROUP
  • Statistics
  • Data Management